1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with tacrolimus in 7 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 17,757 | 2,319 | 6,661 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | tacrolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.18 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asako, H; Baethge, BA; Granger, DN; Kubes, P; Wolf, RE | 1 |
| Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C | 1 |
| Fukao, K; Fukunaga, K; Iijima, T; Otsuka, M; Takada, Y; Taniguchi, H; Todoroki, T; Yuzawa, K | 1 |
| Fukao, K; Fukunaga, K; Otsuka, M; Takada, Y; Taniguchi, H; Yuzawa, K | 1 |
| Al-Harbi, SA; Bak, I; Blasig, IE; Ferdinandy, P; Haines, DD; Mahmoud, FF; Tosaki, A | 1 |
| Fukao, K; Fukunaga, K; Gu, M; Ishiguro, S; Otsuka, M; Seino, K; Takada, Y; Taniguchi, H; Yuzawa, K | 1 |
| Dierkhising, RA; Henke, SA; Kita, H; Madaan, A; Matsuwaki, Y; Plager, DA; Squillace, DL | 1 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and tacrolimus
| Article | Year |
|---|---|
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules.
Topics: Animals; Capillaries; Cell Adhesion; Cell Movement; Cyclosporine; Leukocytes; Leukotriene B4; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tacrolimus; Venules | 1992 |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan | 1993 |
Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Immunosuppressive Agents; Ischemia; Liver; Liver Transplantation; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Swine; Tacrolimus | 1998 |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist.
Topics: Adenine Nucleotides; Animals; Aspartate Aminotransferases; Energy Metabolism; Graft Survival; Ischemia; Liver; Liver Transplantation; Organ Preservation; Piperidines; Platelet Activating Factor; Postoperative Period; Pyridinium Compounds; Swine; Tacrolimus; Temperature; Transplantation, Homologous | 1998 |
Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts.
Topics: Animals; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Electrocardiography; Flavonoids; Free Radical Scavengers; Ginkgo biloba; Hemodynamics; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Plant Extracts; Plants, Medicinal; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Tacrolimus | 2000 |
Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation.
Topics: Animals; Endothelin-1; Graft Survival; Heart Arrest; Liver Transplantation; Peptides, Cyclic; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Swine; Tacrolimus; Time Factors; Tissue and Organ Harvesting; Transplantation, Homologous | 2000 |
Pimecrolimus reduces eosinophil activation associated with calcium mobilization.
Topics: Calcineurin Inhibitors; Calcium; Cell Degranulation; Cell Survival; Cells, Cultured; Eosinophil-Derived Neurotoxin; Eosinophils; Humans; Immunoglobulin A, Secretory; Interleukin-5; Platelet Activating Factor; Superoxides; Tacrolimus | 2009 |